Background {#Sec1}
==========

The value of medical technologies has been questioned with the advent of the global revolution in medical care in recent years. Just like other countries, concerns about the failure of the market mechanism for medical care and the sustainability of universal health insurance coverage have increased even in Japan. An increase in the burden of pain and reduction in benefits are said to be inevitable; thus, the 'value' of medical technology is being questioned with the incorporation of Health Technology Assessments (HTAs) \[[@CR1]\]. HTAs represent an interdisciplinary research area that investigates the impact of medical technologies on health from economic, systematic, social and ethical perspectives while considering possible options. The purpose of the HTA is to provide information for formulating patient-based, safe and effective medical care policies aimed at achieving the very best value. The academic basis for this is pharmacoeconomics. This discipline evaluates the medical impact for a patient through the adaptation of medical technology and the comparative consideration of the required cost. This is essentially a quantification of the relative value of medical technologies and the science of examination of the cash value of medical care \[[@CR2]\]. Therefore, the main objective of the economic evaluation is not to only reduce the cost of medical care but also adopt a fair approach from the perspective of value-based public policy, which facilitates the fair evaluation of innovations in medical care \[[@CR3]\]. There has been much pharmacoeconomics research in medical science but little in the area of dentistry. Thus, this study focuses on the cost of dental care in Japan. Examining the composition of health care renumeration points per day by care type, prosthetic treatment accounted for a higher proportion than other treatments according to reports by the Ministry of Health, Labour and Welfare in Japan \[[@CR4]\]. Therefore, this study undertakes an economic evaluation of prosthetic treatment for intermediate loss of molars. Implants do not invade neighboring teeth. It is an important treatment option in contemporary dental medicine from the viewpoint of "Minimal Intervention" \[[@CR5]\]. In the Japanese public medical care insurance, only the FDP by metals that include gold--silver--palladium or the RPD can be selected for prosthetic treatment of a missing unilateral lower jaw first molar. Therefore, the FDP by hybrid ceramics or porcelain crowns and the implant treatment will be completely self-funded, and medical treatments are not covered by public insurance. So the prosthetic treatment for the intermediate loss of molars involves treatment that mainly uses insurance fixed dental prosthesis (IFDP) (materials: metals that include gold--silver--palladium). Options also include Implants other than insurance adaptation and private fixed dental prosthesis (PFDP) (materials: hybrid ceramics and porcelain crowns). There are health economic assessments concerning Implants \[[@CR5]\]; in previous studies analysing cost-effectiveness using the original survey form, Implants were seen as a dominant strategy compared with fixed dental prosthesis (FDP) \[[@CR6]\]. In addition, in prior studies in South Korea where the endpoint is taken to be the survival rate of the prosthetic device, a 20% reduction in the cost of Implant treatment would result in Implant being more dominant than FDP \[[@CR7]\]. However, to date, there has been little economic assessment research using the measurement of oral quality of life (QOL), which is widely used worldwide in relation to the effect. This study thus aims to undertake a cost effectiveness analysis (CEA) of the prosthetic treatment for the intermediate loss of a single molar to compare Implant and FDP from cost and QOL perspectives.

Methods {#Sec2}
=======

Methods-general {#Sec3}
---------------

### Setting and model {#Sec4}

This study describes a model study using the result of previous research on transition probability \[[@CR7]\]. The study obtained the approval (E2536) of the Ethics Committee of Kyoto University. Written informed consent was obtained from the participants that were included in this study. The analysis had a public health care perspective, testing the optimal decision making for patients concerning health care services. At present in Japan, Implants and PFDPs are not insured medical examination options; accordingly, the study examined whether or not investment in Implants and PFDPs are more beneficial than IFDP when an individual patient thinks about investing in treatment for a prosthetic treatment for intermediate loss of molar. Hence, data was modelled using the Markov model for the assessment. TreeAge Pro 2015 (TreeAge Software Inc., Williamstown, MA, USA) was used for data modelling and analysis.

### Targeted population {#Sec5}

For the QOL parameters for the Markov model, a questionnaire survey was conducted to collect a QOL measurements. The subjects of the survey for the QOL measurements were male and female outpatients (*n* = 560) at the Department of Oral Implantology, Osaka Dental University, aged 37--81 years and who have lost the row of teeth in their lower jaw. The test subjects were classified into four groups, i.e., Implant treatment, FDP treatment, RPD treatment and those who were not treated for the loss.

### Comparators {#Sec6}

Under this model, Implants, PFDPs and IFDPs were set as the decision node for prosthetic treatment of a missing unilateral lower jaw first molar. The model was created so that there would be transition to IFDP in the case of a lost Implant and transition to RPD where the IFDP failed. Regarding the transition probability of the implant, we do not include prosthetic failure and are based on the loss of the implant body. Where the RPD is not provided, the status was considered not treated (Fig. [1](#Fig1){ref-type="fig"}).Fig 1State transition diagram(![](12903_2018_604_Figa_HTML.gif){#d29e440}:initial status)

### Time horizon {#Sec7}

The mean number of missing teeth for persons aged 45--49 years in the Ministry of Health, Labour and Welfare's Survey of Dental Diseases (2011) was 1.5 \[[@CR8]\]. Consequently, under this model, 50 years was adopted as the age for the first prosthetic treatment for the loss of a molar. In addition, since Japanese average life expectancy exceeds 80 years for both men and women, the time horizon of the analysis was set at 30 years.

### Discount rate {#Sec8}

To adjust the future costs and health benefits to a present value at the decision making in terms of the time preference, a discount rate of 2% per year was considered in the analysis in accordance with Japanese guidelines \[[@CR9]\].

Outcome {#Sec9}
-------

### Choice of outcomes {#Sec10}

This study calculated the Incremental Cost-Effectiveness Ratio (ICER) with the CEA. In addition, the Cost-Effectiveness Acceptability Curves (CEAC) for Implant, IFDP and PFDP were plotted and probabilistic and deterministic sensitivity analyses conducted.

### Measurement of effectiveness {#Sec11}

The results of the questionnaire survey for the General Oral Health Assessment Index (GOHAI) \[[@CR10]\], a comprehensive health-related QOL value that relates to the oral cavity, were used for measurements of the effect in this study. GOHAI comprises three areas (subordinate scales) that measure the extent of physical and psychosocial limits on aspects of living caused by oral difficulties. Eating, swallowing and pronunciation are assessed for physical function; aesthetic appreciation and sociability are assessed for psychosocial function. In addition, items such as relating to the use of medicines and hypersensitivity are assessed for pain and discomfort. A total score for 12 items from these three areas is assessed. GOHAI is calculated to be in the range of 12--60, but for this study the GOHAI value was converted to the continuous value between 0 and 1 based on beta distribution (0:no satisfaction, 1:full satisfaction); that is, a converted GOHAI value of 1 for the subjects indicates absolutely no limitations on physical and psychosocial aspects of living. Conversely, 0 indicates pronounced limitations on the physical and psychological aspects of living due to oral difficulties. The subjects of the survey comprised outpatients of the Department of Oral Implantology, Osaka Dental University Hospital between September 2014 and March 2016. In addition, a bias in the QOL due to missing teeth is expected when assessing the QOL value of the subjects. Thus, the target analysis under this study was the calculation of QOL value for each prosthetic device, with a separate classification of the missing teeth by the Kennedy Classification and the Eichner Classification systems. Furthermore, the accumulation of GOHAI was done after registering the application to use iHope International K.K.'s QOL scale. Expert opinion was used due to lack of previous research.

### Modeled parameters {#Sec12}

Data from previous research were used for transition probability and sourced from three systematic reviews \[[@CR11]--[@CR13]\] and three retrospective cohort studies \[[@CR14]--[@CR16]\]. In addition, annual mortality rates were calculated using the FY2013 Abridged Life Table from the life table published by the Statistics Bureau of the Ministry of Internal Affairs and Communications in Japan \[[@CR17]\]. For one issue (the failure rate of renewed FDP treatment), the calculation was based only on expert opinion. The annual failure rate of each type of prosthetic device, the distribution and probability of treatment following failure, annual mortality rate and the parameters for the data source are presented in Table [1](#Tab1){ref-type="table"}.Table 1Distributions of annual failure rates and allocation on several stages used in the modelStateAnnual failure rate (%)AllocationData sourceAllocated toProb.Implant0.52second Implant1Jung et al. (2012) \[[@CR11]\] (systematic review)second Implant2IFDP1Mardinger et al. (2012) \[[@CR14]\] (retrospective)IFDP11second IFDP0.998Aoyama et al. (2008) \[[@CR15]\] (retrospective)RPD0.002Pjetursson et al. (2007) \[[@CR12]\] (systermatic review)second IFDP15RPD1assumptionPFDP4.4second PFDP0.998Torabinehad et al. (2007) \[[@CR13]\] (systematic review)RPD0.002Pjetursson et al. (2007) \[[@CR12]\] (systermatic review)second PFDP8.4RPD1assumptionRPD16.8MT1Jepson et al. (1995) \[[@CR16]\] (retrospective)all state50 years: 0.0016dead1e-stat <https://www.e-stat.go.jp/SG1/estat/GLO8020103.do?_toGLO8020103_&listID=000001120139&requestSender=dsearch>51 years: 0.0017:80 years: 0.0252

Costs {#Sec13}
-----

Since the study was conducted in Japan, the calculating process of the cost parameters conformed to Japanese medical care insurance system. An exchange rate of €1 = ¥114.60 (as at 26 July 2016) was used \[[@CR18]\], and gamma distribution was adopted as the distribution in the probabilistic sensitivity analysis for cost of each treatment. PFDP is not an insured procedure under the public medical care insurance system, and the fee for medical services is not fixed; therefore, reference was made to the general cost of treatment in Japan. For Implants, there have been allowances of some insured procedures in Japan (cases where jawbones have been lost or damaged extensively due to disease or accident). This study calculated the cost equivalent for one missing tooth referring to the applied medical service fee.

Results {#Sec14}
=======

Study parameters {#Sec15}
----------------

Table [2](#Tab2){ref-type="table"} shows the results of the beta distribution of the GOHAI value used in this study converted to 0 and 1. The results for lost Implants and lost FDP are also reported. In this study, subjects who have undergone Implants with the Kennedy Classification of level 2 and Eichner Classifications of B1 and B2 (loss of tooth) are considered to be in the Implant group. This corresponds to 168 Implant patient with a QOL value of 0.88 ± 0.14. In addition, Table [3](#Tab3){ref-type="table"} illustrates the cost of prosthetic treatment and the post treatment maintenance cost.Table 2Patient's satisfaction survey on several stagesStateKennedy ClassificationEichner ClassificationDistributionNo. of patientsAge Mean ± 1SDDistribution parameters Mean ± 1SDImplantBeta16861.7 ± 9.80.88 ± 0.14IIB1-B2lost ImplantBeta3261.1 ± 9.40.71 ± 0.23FDPBeta6559.0 ± 11.40.83 ± 0.13IIIA2-A3-B1-B2lost FDPBeta6654.8 ± 11.50.68 ± 0.17RPDII-IIIB1-B2Beta4563.8 ± 10.30.71 ± 0.23MTIIB1-B2Beta18459.1 ± 11.00.70 ± 0.18Table 3Cost survey on several stages. (€)StateDistributionDistibution Mean ± 1SD (€)Data sourceImplantGamma2744 ± 274.4Interpolated fromhealth insurance treatment costsof JapanIFDPGamma420 ± 42.0Health insurance treatment costsof JapanPFDPGamma2618 ± 261.8Private practiceImplant•FDP•MT maintenanceGamma261.8 ± 26.2Interpolated from health insurance treatment costs of JapanRPDGamma368 ± 36.8Health insurance treatement costs of JapanRPD maintenanceGamma305 ± 43.6Health insurance treatment costs of Japan

Incremental costs and effectiveness {#Sec16}
-----------------------------------

The results plotted for the cost and effect of the three groups in the cost-effectiveness plane are shown in Fig. [2](#Fig2){ref-type="fig"}. PFDP is to the upper left of the direct line for IFDP and Implants, indicating it to be extended dominated. The results for the calculated ICER are shown in Table [4](#Tab4){ref-type="table"}. The cost difference between Implant and IFDP is €1849.90, while the difference in effectiveness is 1.3; thus, the ICER was €1423.00.Fig. 2Results of cost-effectiveness analysisTable 4Incremental cost-effectiveness ratios of Implant versus IFDPCategoryStrategyCostIncr costEffIncr effIncr C/E (ICER)Excluding dominated UndominatedIFDP6611.217.8 UndominatedImplant8461.11849.919.11.31423

Characterizing uncertainty {#Sec17}
--------------------------

As a probabilistic sensitivity analysis, the results using Monte-Carlo simulations repeated 5000 times were plotted on the cost effectiveness plane (Fig. [3](#Fig3){ref-type="fig"}). The IFDP and PFDP points are widely distributed, but Implants are concentrated on the right-hand side of the plane compared with the other two groups. The CEAC is shown in Fig. [4](#Fig4){ref-type="fig"}. This illustrates how IFDP has a higher permissibility than other treatments where the willingness to pay (WTP) threshold is low. In addition, admissibility also commenced for PDFP at over €3000. The results of a deterministic sensitivity analysis are illustrated in Fig. [5](#Fig5){ref-type="fig"}. The results of 1-way sensitivity analysis shown in the Tornado diagram indicate the variable with the largest level of variation in the ICER to be the parameter of not treating the missing tooth, which indicates the high priority for additional research. In addition, the QOL value for Implant has a much larger impact on ICER than the Implant failure rate.Fig. 3The cost-effectiveness plane (Monte-Carlo simulation)Fig. 4Cost-effectiveness acceptability curvesFig. 5Sensitivity analysis comparing Implant and IFDP (Tornado diagram)

Discussion {#Sec18}
==========

Study finding {#Sec19}
-------------

To the best of our knowledge, this study is the first health economic evaluation using Japanese medical care data (cost/QOL value) for prosthetic treatment of intermediate loss of a single tooth in the molar region. In addition, studies of cost-effectiveness in dentistry often take the survival period to be the effectiveness \[[@CR7], [@CR19]\]; however, this study assessed the effect from a QOL perspective. In previous research, cost effectiveness has been examined using independent questionnaires to measure QOL \[[@CR20]\]; instead, this study used GOHAI, which is considered appropriate for measuring QOL from a suitability perspective. Such a result is considered useful not only from the perspective of the patient satisfaction level but also for designing insurance policies. Limitations of the study include that there was inevitable reliance on three retrospective cohort studies on treatment transition probabilities and that the re-application of the same prosthetic treatment following the failure of an Implant and FDP was restricted to only once. This research is focusing on a single intermediate missing tooth in the first molar, but the condition of the dentition in other parts is unknown. The state of the dentition of the other part is adjusted so as not to be biased by the Kennedy Classification and the Eichner Classification systems. However, the life and death of the pulp is unknown. Also we have chosen to not include IFDP as a transition from a failed PFDP. In addition, the QOL measurement used in this study is a potential limitation for the ability to generalise the results since the data source was from a single institution. Longitudinal data has to be collected from other institutions in future. The current situation for the medical field in Japan is that there are health institutions for the Diagnosis Procedure Combination (DPC) system and a documented database of fees for medical services for public health insurance and cooperative insurance. Observational studies that rival randomised controlled trials (RCTs) have been implemented by understanding and being reminded of the features of such large data \[[@CR21], [@CR22]\]. However, there is currently a lack of data being collected across other institutions in the area of dentistry, particularly in relation to Implants. In terms of the advancement of clinical research, construction of a database that permits identification and access to necessary information simply and rapidly is vital for developing the study of Implants.

Effectiveness cost {#Sec20}
------------------

According to the report from Naito et al., Japanese national norm for GOHAI is 52.2 ± 7.8 (0.84 ± 0.16 when converted to 0 to 1) for 50--59-year-olds \[[@CR23]\]. Comparing with this result, the results of the current study can be considered the same as Implants and FDP that perform well over time. That is, lost Implants and removed FDP do not function as well as the national norms. In Japan, the medical care necessary to stay healthy and alive, such as for recovery from sickness and disability, delayed progress of sickness and disability, maintenance of physical and mental functions, is adapted from public medical care insurance according to the universal healthcare system. As a patient's co-payment, patients aged 6--69 years pay 30% of medical care costs at reception while infants aged 0--5 years pay 20% (separate public subsidies provided by local governments) and elderly persons aged 70 and above pay 10% (or 30% depending on income). Unrelated to this, medical care for procedures such as cosmetic surgery, orthodontics and sex reassignment surgery are completely self-funded, and medical treatments are not covered by public insurance. IFDP in this study is adapted for public medical care insurance, whereas PFDP corresponds to self-funded medical treatment. Implants also generally correspond to self-funded medical treatment, but some are adapted for public medical care insurance; thus, the analysis refers to those cost data. The cost for Implants under self-funded medical treatment in Japan is approximately €2747.50--3927.50.

Main result {#Sec21}
-----------

In this study, starting with an Implant for the prosthetic treatment of a single missing tooth in the molar region of the lower jaw had a higher QOL condition than either IFDP or PFDP. However, IFDP had the lowest cost among the three groups when estimated for 30 years. In addition, it became clear that PFDP is an extended dominated ~~state~~ relative to IFDP and Implant. There was a trend for these results to resemble the cost effectiveness research for Implants and FDP conducted previously \[[@CR6], [@CR7], [@CR20]\]. However, the method of analysis, including the one used in this study, has not been a cost--utility analysis (CUA); instead, all were cost-effectiveness analyses, and there was no consistency in the effectiveness index. Within the realm of medicine, EuroQOL-5Dimension (EQ-5D), Structured Form 6 Dimension (SF-6D) \[[@CR24]\], Healthy Utility Index (HUI) \[[@CR25]\] and other preference-base QOL questionnaire forms are used to calculate the Quality-Adjusted Life Year (QALY), which is an indicator used for CUA. However, in previous studies using such QOL forms, no calculations have been made for the detailed difference in the condition of the oral cavity. A report by Shiroiwa et al. confirmed a significant decline in the QOL value with SF-6D due to tooth disorder but did not confirm a significant difference with EQ-5D \[[@CR24]\]. However, the detailed condition of the oral cavity was unknown in this result. In future, missing tooth treatments need to be assessed with particular focus on the different types.

Conclusion {#Sec22}
==========

The study results suggest a better QOL can be obtained from an Implant than from IFDP or PFDP. However, the Tornado diagram in the deterministic sensitivity analysis suggests that additional research is required, particularly in relation to the QOL value for when a missing tooth is not treated. An evaluation form using an indexed scale for oral health related aspects needs to be developed that is also consistent as an indicator of effect. If this can be used to understand the extent to which the oral environment has an impact on the QOL by setting a standardised value for the state of oral health condition of citizens, then it could also achieve a CUA.
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